ArticleCancer immunology, immunotherapy : CII2026

Novel recombinant protein PK5-Gal-3C enhances the anti-tumor activity of T cells via binding with TRPV2.

Guopeng Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.